Acute Hepatic Porphyria Drugs Market Size

Acute Hepatic Porphyria Treatment Market size was valued at USD 4.23 billion in 2024 and is likely to cross USD 8.08 billion by 2037, expanding at more than 5.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of acute hepatic porphyria treatment is assessed at USD 4.41 billion.

The acute hepatic porphyria treatment market is thriving on the back of growing awareness among the people regarding this disease coupled with the growing research activities.